Oliver Lagore Vanvalin Investment Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$163K Buy
+986
New +$152K 0.06% 147
2024
Q4
$144K Buy
999
+13
+1% +$2.02K 0.04% 140
2024
Q3
$160K Sell
986
-90
-8% -$14.3K 0.04% 135
2024
Q2
$157K Sell
1,076
-333
-24% -$49.5K 0.05% 133
2024
Q1
$223K Sell
1,409
-4,531
-76% -$721K 0.07% 121
2023
Q4
$931K Buy
5,940
+2
+0% +$307 0.35% 54
2023
Q3
$925K Buy
5,938
+231
+4% +$38.1K 0.37% 44
2023
Q2
$945K Buy
5,707
+1,865
+49% +$301K 0.35% 47
2023
Q1
$595K Buy
3,842
+711
+23% +$115K 0.25% 45
2022
Q4
$553K Sell
3,131
-1,790
-36% -$309K 0.31% 43
2022
Q3
$804K Buy
4,921
+933
+23% +$158K 0.52% 31
2022
Q2
$708K Buy
3,988
+351
+10% +$62.5K 0.41% 38
2022
Q1
$634K Sell
3,637
-28,723
-89% -$4.89M 0.42% 42
2021
Q4
$5.54M Buy
+32,360
New +$5.3M 0.4% 38

Other funds holding JNJ

Oliver Lagore Vanvalin Investment Group's JNJ Position: Q2 2025 in Review

Oliver Lagore Vanvalin Investment Group opened a new position in Johnson & Johnson (JNJ) in Q2 2025: 986 shares worth $163K. The stake represents 0.06% of the portfolio and ranks #147 among its holdings. This is a return to the name: Oliver Lagore Vanvalin Investment Group previously reported a position in JNJ as recently as Q4 2024.

Oliver Lagore Vanvalin Investment Group first reported a position in JNJ in Q4 2021 and has held it in 14 quarters since. The position peaked at $5.54M in Q4 2021. 4,083 funds tracked by Wall St. Rank hold JNJ as of Q2 2025.

  • Oliver Lagore Vanvalin Investment Group held 986 shares of Johnson & Johnson worth $163K as of Q2 2025.
  • Johnson & Johnson was a new Oliver Lagore Vanvalin Investment Group position in Q2 2025.
  • Johnson & Johnson made up 0.06% of Oliver Lagore Vanvalin Investment Group's portfolio in Q2 2025, its #147 holding.
  • Oliver Lagore Vanvalin Investment Group first reported a position in Johnson & Johnson in Q4 2021 and has held it in 14 quarters since.
  • Oliver Lagore Vanvalin Investment Group's Johnson & Johnson position peaked at $5.54M in Q4 2021.
  • 4,083 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2025.

Based on Oliver Lagore Vanvalin Investment Group's 13F filing for Q2 2025, filed 10 Jul 2025.